
Organic Process Research and Development p. 1908 - 1917 (2019)
Update date:2022-07-29
Topics:
Baenziger, Markus
Pachinger, Werner
Stauffer, Frédéric
Zaugg, Werner
The development of the robust synthesis of 2-methyl-2-[4-[3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydro-1H-imidazo[4,5-c]quinolin-1-yl]-phenyl]propionitrile (dactolisib) on a commercial scale is described. The key step is a Pd-catalyzed Suzuki coupling of 2-[4-(8-bromo-3-methyl-2-oxo-2,3-dihydro-1H-imidazo[4,5-c]quinolin-1-yl)-phenyl]-2-methyl-propionitrile to 3-quinoline boronic acid. A special focus is placed on reducing the amount of Pd catalyst used in the Suzuki coupling and purifying the crude drug substance, including removing traces of Pd.
View MoreBinzhou Holly Pharmaceutical Co.,Ltd.
Contact:74517
Address:No.15 Dapu Road,Huangpu District Shanghai,P.R.China
Hebei DaPeng Pharm & Chem Co., Ltd.
Contact:86-317-7298678,0576-88861898 88861908
Address:West Songmen Village, East Songmen Town, Wuqiao, Cangzhou, Hebei ,China
Contact:86-371-63655023
Address:No.85,jinshui road,zhengzhou,China
Jinan Trio PharmaTech Co., Ltd
Contact:86-531-88811783;+(0)13153010282
Address:2766 Yingxiu Road, Jinan High-Tech Zone, China
Luzhou North Chemical Co., Ltd.
Contact:+86-830-2796784;+86-830-2796776
Address:Gaoba, Longmatan District, Luzhou, Sichuan Province
Doi:10.1021/acschembio.8b00909
(2018)Doi:10.1016/j.ejmech.2014.04.039
(2014)Doi:10.1021/ja5038337
(2014)Doi:10.1021/ol501254h
(2014)Doi:10.1039/c39950000067
(1995)Doi:10.1055/s-1994-25694
(1994)